Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minimum Oxytocin Dose for Cesarean During Labor
NCT02794779Phase 3Unknown
- Sponsor
- Hospital Universitário de Brasília
- Start
- Jul 2016
- Primary completion
- Dec 2017
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of oxytocin in postpartum hemorrhage (PPH) and uterine atony (2 arms), sponsored by Hospital Universitário de Brasília. Primary endpoint: Minimum Effective Dose of Oxytocin (ED90) at 10 minutes. Status: unknown.
02
Drugs
oxytocin
03
Conditions
postpartum hemorrhage (PPH)uterine atony
Beyond the preview
Go deeper on NCT02794779.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02794779.